Zhongsheng Group Holdings Limited

Equities

881

KYG9894K1085

Auto Vehicles, Parts & Service Retailers

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
13.56 HKD +10.24% Intraday chart for Zhongsheng Group Holdings Limited +2.11% -27.41%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Beijing Outlook, Ex-Dividend Dates Roil Asian Stock Markets MT
Zhongsheng Group's 2023 Profit Falls on Lower Revenue; New CFO Named MT
Zhongsheng Group Holdings Limited Appoints Yu Ning as Chief Financial Officer CI
Zhongsheng Group Holdings Limited Announces Appointment of Executive Directors CI
Zhongsheng Group Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024 CI
Zhongsheng Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tech Sector, Earnings, Wall Street Cues Churn Asian Stock Marlets MT
Zhongsheng Pharma's Chairman to Raise Stake in Company MT
Zhongsheng Group Holdings Limited(SEHK:881) dropped from Hang Seng China Enterprises Index CI
US Tech Outlook Boost Asian Stock Markets MT
Renaissance Asia Silk Road to Issue 800 Million Shares; Shares Tank 9% MT
Zhongsheng Pharma's Unit Gets Nod to Market Mirabegron MT
Henan Jinyuan Hydrogenated Chemicals Launches Up to HK$358 Million Hong Kong IPO Following Spin-Off from Parent MT
Zhongsheng Pharma Chairman Plans Boosting Stake MT
Manufacturing Outlook Limits Asian Stock Markets MT
Tiantan Biological Products Secures Another Blood Collection License MT
Zhongsheng Pharmaceutical Gets Drug Registration Certificate for Carbocysteine Oral Solution MT
Middle East Turmoil, Crude Prices Roil Asian Markets in Holiday-Thinned Trading MT
Beijing Tiantan Biological Products Lands Blood Collection License in China’s Liping County MT
Zhongsheng Group's Profit Drops 12.8% in H1 MT
Zhongsheng Group Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Bargain Hunting Lifts Asian Stock Markets MT
Zhongsheng Pharmaceutical Gets Nod to Register Moxifloxacin Hydrochloride Eye Drops MT
Chairman, Controlling Shareholder Boosts Stake in Zhongsheng Group MT
Zhongsheng Group Holdings Limited commences an Equity Buyback Plan for 240,182,336 shares, representing 10% of its issued share capital, under the authorization approved on June 19, 2023. CI
Chart Zhongsheng Group Holdings Limited
More charts
Zhongsheng Group Holdings Limited is specialized in vehicle distribution. The group offers light luxury vehicles (Mercedes-Benz, Lexus, BMW, Audi, etc.) and medium and high-end vehicles (Toyota, Honda, Nissan, Volvo, Land Rover, etc.). Sales by activity are broken down as follows - new vehicle sales (81.4%): 528,154 units sold in 2021; - after-sales services (14%). In addition, the group offers the sale of accessories; - used car sales (4.6%): 139,413 units sold. At the end of 2021, Zhongsheng Group Holdings Limited has 412 dealerships in China. All sales are generated in China.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
12.52 CNY
Average target price
19.41 CNY
Spread / Average Target
+54.98%
Consensus
  1. Stock
  2. Equities
  3. Stock Zhongsheng Group Holdings Limited - Hong Kong S.E.
  4. News Zhongsheng Group Holdings Limited
  5. Zhongsheng : Forms Strategic Alliance with EV Startup Xpeng; Shares Rally 3%